Congress Trades

Latest disclosures

Chamber Transaction Date Member Owner Asset Action Amount Ticker ▲ Δ Since Trade
House Mar. 11, 2025 Rob Bresnahan REDDIT INC SALE $1,001 - $15,000 RDDT ▲ +52.99%
House Feb. 14, 2025 Rob Bresnahan REDDIT INC PURCHASE $1,001 - $15,000 RDDT ▼ -4.38%
Senate Jan. 4, 2018 Shelley Moore Capito Spouse Royal Dutch Shell plc SALE (PARTIAL) $1,001 - $15,000 RDS-A ▲ +0.00%
Senate Jan. 4, 2018 Shelley Moore Capito Spouse Royal Dutch Shell plc SALE (PARTIAL) $1,001 - $15,000 RDS-A ▲ +0.00%
Senate Jul. 26, 2021 Shelley Moore Capito Spouse Royal Dutch Shell Plc SALE (PARTIAL) $1,001 - $15,000 RDSA
Senate Jun. 10, 2019 Shelley Moore Capito Spouse Royal Dutch Shell plc SALE (PARTIAL) $1,001 - $15,000 RDSA.AS
Senate Aug. 21, 2020 Jerry Moran Self Royal Dutch Shell plc SALE (FULL) $1,001 - $15,000 RDS-B ▲ +82.23%
Senate Jun. 4, 2020 Ron Wyden Spouse Royal Dutch Shell plc SALE (FULL) $1,001 - $15,000 RDS-B ▲ +50.75%
Senate Apr. 6, 2020 Ron Wyden Spouse Royal Dutch Shell plc PURCHASE $1,001 - $15,000 RDS-B ▲ +42.99%
Senate Dec. 6, 2018 Jerry Moran Spouse Royal Dutch Shell plc PURCHASE $1,001 - $15,000 RDS-B ▼ -15.98%
Senate Dec. 19, 2018 Jerry Moran Self Royal Dutch Shell plc SALE (PARTIAL) $1,001 - $15,000 RDS-B ▼ -12.45%
Senate Mar. 11, 2019 Shelley Moore Capito Spouse Royal Dutch Shell plc SALE (FULL) $1,001 - $15,000 RDS-B ▼ -18.23%
House Oct. 14, 2024 Ro Khanna Everest Re Group Ltd PURCHASE $1,001 - $15,000 RE ▲ +0.00%
Senate Apr. 4, 2024 Tommy Tuberville Joint Regeneron Pharmaceuticals, Inc. - Common Stock SALE (FULL) $1,001 - $15,000 REGN ▼ -32.98%
Senate Apr. 3, 2023 Tommy Tuberville Joint Regeneron Pharmaceuticals, Inc. - Common Stock PURCHASE $1,001 - $15,000 REGN ▼ -23.99%
House Feb. 12, 2025 Julie Johnson Joint Regeneron Pharmaceuticals Inc SALE $1,001 - $15,000 REGN ▼ -5.40%
Senate Mar. 29, 2021 Tommy Tuberville Joint Regeneron Pharmaceuticals, Inc. PURCHASE $1,001 - $15,000 REGN ▲ +30.42%
House Jul. 1, 2024 Josh Gottheimer Joint Regeneron Pharmaceuticals, Inc. - Common Stock SALE (PARTIAL) $1,001 - $15,000 REGN ▼ -40.59%
House Aug. 11, 2023 Greg Landsman Spouse Regeneron Pharmaceuticals, Inc. - Common Stock PURCHASE $1,001 - $15,000 REGN ▼ -22.18%
House Jan. 15, 2025 Julie Johnson Joint Regeneron Pharmaceuticals Inc PURCHASE $1,001 - $15,000 REGN ▼ -10.72%
House Jan. 24, 2025 Josh Gottheimer Joint Regeneron Pharmaceuticals Inc SALE $1,001 - $15,000 REGN ▼ -7.07%
House Nov. 1, 2024 Jonathan Jackson Joint Regeneron Pharmaceuticals Inc SALE $1,001 - $15,000 REGN ▼ -25.56%
House Nov. 13, 2024 Jonathan Jackson Joint Regeneron Pharmaceuticals Inc SALE $15,001 - $50,000 REGN ▼ -21.92%
House Nov. 29, 2024 Josh Gottheimer Joint Regeneron Pharmaceuticals, Inc. - Common Stock SALE (PARTIAL) $1,001 - $15,000 REGN ▼ -16.29%
House Nov. 19, 2024 Josh Gottheimer Joint Regeneron Pharmaceuticals, Inc. - Common Stock SALE (PARTIAL) $1,001 - $15,000 REGN ▼ -15.66%
House Oct. 15, 2024 Greg Landsman Spouse Regeneron Pharmaceuticals Inc SALE $1,001 - $15,000 REGN ▼ -38.22%
House Sep. 9, 2024 Ro Khanna Spouse Regeneron Pharmaceuticals Inc PURCHASE $1,001 - $15,000 REGN ▼ -45.14%
Senate Mar. 30, 2022 Tommy Tuberville Joint Regeneron Pharmaceuticals, Inc. - Common Stock SALE (FULL) $1,001 - $15,000 REGN ▼ -9.30%
Senate Apr. 3, 2023 Tommy Tuberville Joint Regeneron Pharmaceuticals, Inc. - Common Stock PURCHASE $1,001 - $15,000 REGN ▼ -23.99%
House Apr. 10, 2025 Byron Donalds Regeneron Pharmaceuticals Inc SALE $1,001 - $15,000 REGN ▲ +14.94%
Last updated: Nov 5, 12:53